- Home
- PROK vs AISP Comparison
PROK vs AISP Comparison
Compare PROK & AISP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- AISP
- Stock Information
- Founded
- PROK 2015
- AISP 2006
- Country
- PROK United States
- AISP United States
- Employees
- PROK N/A
- AISP N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- AISP Blank Checks
- Sector
- PROK Health Care
- AISP Finance
- Exchange
- PROK Nasdaq
- AISP Nasdaq
- Market Cap
- PROK 94.9M
- AISP 107.6M
- IPO Year
- PROK N/A
- AISP N/A
- Fundamental
- Price
- PROK $0.81
- AISP $4.43
- Analyst Decision
- PROK Buy
- AISP Strong Buy
- Analyst Count
- PROK 4
- AISP 2
- Target Price
- PROK $5.00
- AISP $9.00
- AVG Volume (30 Days)
- PROK 796.9K
- AISP 550.9K
- Earning Date
- PROK 05-12-2025
- AISP 05-15-2025
- Dividend Yield
- PROK N/A
- AISP N/A
- EPS Growth
- PROK N/A
- AISP N/A
- EPS
- PROK N/A
- AISP N/A
- Revenue
- PROK $306,000.00
- AISP $17,978,226.00
- Revenue This Year
- PROK N/A
- AISP $34.30
- Revenue Next Year
- PROK N/A
- AISP $59.47
- P/E Ratio
- PROK N/A
- AISP N/A
- Revenue Growth
- PROK N/A
- AISP N/A
- 52 Week Low
- PROK $0.46
- AISP $1.90
- 52 Week High
- PROK $4.44
- AISP $7.66
- Technical
- Relative Strength Index (RSI)
- PROK 49.17
- AISP 59.55
- Support Level
- PROK $0.94
- AISP $3.92
- Resistance Level
- PROK $0.87
- AISP $4.47
- Average True Range (ATR)
- PROK 0.11
- AISP 0.26
- MACD
- PROK 0.01
- AISP 0.05
- Stochastic Oscillator
- PROK 39.10
- AISP 90.36
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About AISP Airship AI Holdings Inc.
Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where they need it, using a highly secure permission-based architecture.